We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
British American Tobacco Plc | LSE:BATS | London | Ordinary Share | GB0002875804 | ORD 25P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-13.00 | -0.55% | 2,333.00 | 2,332.00 | 2,333.00 | 2,359.00 | 2,332.00 | 2,348.00 | 4,783,120 | 15:13:53 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Cigarettes | 27.72B | -14.37B | -6.4241 | -3.67 | 52.69B |
By Dieter Holger
British American Tobacco PLC (BATS.LN) has increased the markets its smokeless products are sold in as it transitions away from cigarettes, the company said Tuesday.
Some 29 markets world-wide now offer smokeless merchandise that the company bills as "potentially reduced-risk products," up from 18 in 2017. These products are "closely aligned" with the United Nations sustainable development goal of "good health and well-being," BAT said.
The merchandise includes electronic cigarettes for inhaling nicotine-laced vapor, tobacco heating products and oral products such as snus, which is powder tobacco placed in the upper lip that is popular in Sweden, the company said.
BAT said these products are less harmful than cigarettes.
"No tobacco or nicotine product is 100% safe," BAT said. "However, it is widely accepted that most of the harm associated with smoking is caused by inhaling the smoke produced by burning tobacco and not by nicotine."
BAT said its research and development is now mostly focused on providing new technologies for less-harmful nicotine products.
The company also said the number of published peer-reviewed articles and manuscripts researching the health risks of PRRPs compared to cigarettes went up to 64 in 2018 from 46 in 2017.
"While more third-party research--from regulators, academia and tobacco control campaigners--is undoubtedly needed, we are encouraged by the amount of independent evidence pointing to the potential of PRRPs to significantly reduce harm," BAT said.
Write to Dieter Holger at dieter.holger@dowjones.com; @dieterholger
(END) Dow Jones Newswires
March 19, 2019 10:46 ET (14:46 GMT)
Copyright (c) 2019 Dow Jones & Company, Inc.
1 Year British American Tobacco Chart |
1 Month British American Tobacco Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions